The Makings of a Tumor Rejection Antigen-Reference-Cited by-同舟云学术

The Makings of a Tumor Rejection Antigen

Published:1999-09 Issue:3 Volume:11 Page:263-270
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Gilboa Eli

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference81 articles.

1. Selective expansion of high or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy;Alexander-Miller;Proc. Natl. Acad. Sci. USA,1996

2. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL;Alexander-Miller;J. Exp. Med.,1996

3. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma;Anichini;J. Immunol.,1996

4. Bone marrow-generated dendritic cell pulsed with tumor extracts or tumor RNA induce anti-tumor immunity against central nervous system tumors;Ashley;J. Exp. Med.,1997

5. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo;Boczkowski;J. Exp. Med.,1996

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma;Indian Journal of Clinical Biochemistry;2023-10-14

2. Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma;INDIAN J CLIN BIOCHE;2023

3. The Value of Microbes in Cancer Neoantigen Immunotherapy;Pharmaceutics;2023-08-14

4. Advances in dendritic cell vaccination therapy of cancer;Biomedicine & Pharmacotherapy;2023-08

5. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer;Journal for ImmunoTherapy of Cancer;2023-08